Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter
Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter
